OPTN

Optinose Technology Inventor Per Djupesland Named Winner of European Inventor Award 2021 for Industry

Experts Issue New Treatment Algorithm for Chronic Rhinosinusitis with Nasal Polyps That Highlights Role of XHANCE® In Stepwise Care

OptiNose, Inc. (OPTN) CEO Peter Miller on Q1 2021 Results - Earnings Call Transcript

OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates

New Harris Survey Reveals Chronic Nasal Congestion Is Surprisingly Widespread: Nearly 1 in 4 Americans With Nasal Congestion Experience Symptoms Almost Every Day

Optinose to Present at the Needham Virtual Healthcare Conference

OptiNose's (OPTN) CEO Peter Miller on Q4 2020 Results - Earnings Call Transcript